03 Profile
Vital Signsby Bridgehead
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Respiratory (asthma/COPD)
Iilun Murphy: no photograph is held, so the academic plate is shown instead.
Academic
Iilun Murphy
M.D., director of the Office of Generic Drugs in the FDA's Center for Drug Evaluation and Research
1
0
0
0
0
0
0
0
0
Mar 2026AprMayJuneJulyAugSeptOctNovto date
1
press citation on 1 topic since 5 Mar 2026 · last quoted 5 Mar 2026
02 Quoted on · 1 of 29 topics
Iilun Murphy: key facts
- Kind of voice
- Academic
- Role
- M.D., director of the Office of Generic Drugs in the FDA's Center for Drug Evaluation and Research
- Quoted on
- Respiratory (asthma/COPD)
- Tracked press citations
- 1
- Most recently quoted
- 5 Mar 2026
04 On the record · press
What Iilun Murphy has said
By outlet · linked articles
- fiercepharma.com1
Where Iilun Murphy has been quoted
- 01FDA gives Glenmark thumbs up for first 'true' generic version of GSK's asthma inhaler Floventfiercepharma.com · 5 Mar 2026
Verbatim
“Today's approval of the first generic fluticasone propionate inhalation aerosol represents an important step in expanding access to affordable asthma treatment.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 13 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.